Quidel to Present at 35th Annual J.P. Morgan Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Quidel to Present at 35th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, CA --(Marketwired - December 20, 2016) - Quidel Corporation ( NASDAQ : QDEL ) , a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 35 th Annual J.P. Morgan Healthcare Conference to be held at The Westin St. Francis hotel in San Francisco, California on Tuesday, January 10, 2017.

Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present that day at 10:30 a.m. Eastern time (7:30 a.m. Pacific time) with a question and answer session scheduled immediately following the presentation. During the presentation, the company will discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.

A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company's Web site at http://ir.quidel.com/ , or by accessing the following link:

http://jpmorgan.metameetings.com/confbook/hea...hp?p=22519

Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company's Web site for 14 days.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the Sofia®, QuickVue®, D3® Direct Detection and Thyretain ® leading brand names, as well as under the new Solana®, AmpliVue® and Lyra® molecular diagnostic brands, Quidel's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza , respiratory syncytial virus , Strep A, herpes, pregnancy, thyroid disease and fecal occult blood . Quidel's research and development engine is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians' offices and hospital and reference laboratories. For more information about Quidel's comprehensive product portfolio, visit quidel.com .

Quidel Contact: Quidel Corporation Randy Steward Chief Financial Officer (858) 552-7931 Media and Investors Contact: Quidel Corporation Ruben Argueta (858) 646-8023 Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mausam Bhatt Joins Cars.com as Chief Product Officer

Updated Category News Views 82

Shifting Gears with a New Leader Sometimes the name alone isn't enough to get things rolling, but when someone who's built billion-dollar platforms from scratch joins your team, the engine's ready to roar. That's the motor firing up at Cars.com with Mausam Bhatt behind the wheel as their fresh Chief Product Officer. If you think a new set of eyes can only see what's...

Continue Reading
Jay Group Expands to Houston with New Fulfillment Hub

Updated Category News Views 67

Jay Group's Bold Move in the Logistics Arena In a no-holds-barred expansion, Jay Group's got themselves a brand new sprawling 250,000-square-foot fulfillment hub deep in the heart of Houston. Now, folks, this isn’t just another warehouse. We're talking a 3PL powerhouse that allows coast-to-coast delivery, hitting 90% of U.S. consumers in just a couple of days. If you're...

Continue Reading
Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Updated Category News Views 22

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Continue Reading
Arctic Wolf Leads in AI SOC: A 2026 Game Changer

Updated Category News Views 45

Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...

Continue Reading
Static Media Acquires CarScoops to Boost Auto Reach

Updated Category News Views 47

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...

Continue Reading
EDB Enhances Postgres with Horizontal Scaling Preview

Updated Category News Views 57

EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...

Continue Reading
A. O. Smith Reports Q3 2026: A Strategic Shift

Updated Category News Views 36

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 35

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 70

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading
Pelvic Health Initiative Aids Women in Need

Updated Category News Views 83

Stepping Up For Better Health You don't see this kind of news getting plastered across the financial pages much—the human side of health. EliHealth Initiative's making strides in a realm many don’t even want to openly discuss: bladder leaks in women. Sounds unglamorous, maybe, but for millions, it's a daily ordeal. Slapping on pads and plotting bathroom routes? That's...

Continue Reading

Top 5 Most Recently Viewed Articles

Crown Electrokinetics Faces Challenges Amid Revenue Growth

Updated Category News Views 128

Crown Electrokinetics Corp. Stock Reaches 52-Week Low Crown Electrokinetics Corp. (CRKN) is currently facing a significant downturn, with its stock prices hitting a 52-week low of just $0.12 and a market capitalization of $8.33 million. This decline comes as the company experiences a staggering 1-year drop of -99.36%. It’s clear from the current market indicators,...

Continue Reading
Diagnostic Imaging Market Predicted to Surge to $70 Billion!

Updated Category News Views 127

Overview of the Diagnostic Imaging Market The global diagnostic imaging market has been experiencing significant growth, with its size expected to soar from USD 19.2 billion recently to approximately USD 70.02 billion in the years to come. This remarkable leap indicates a compound annual growth rate (CAGR) of about 13.81% from recent years and reflects the increasing...

Continue Reading
Ginkgo Bioworks Celebrates Key Milestone in Merck Partnership

Updated Category News Views 96

Ginkgo Bioworks Marks a Milestone with Merck Ginkgo Bioworks (NYSE: DNA), a leader in cell programming and biosecurity, has recently announced a significant advancement in its ongoing collaboration with Merck, also known as MSD in some regions. This partnership is focused on enhancing biologic manufacturing processes, and Ginkgo has successfully completed the first...

Continue Reading
Metsera CEO to Present at Key Health Care Conference Soon

Updated Category News Views 116

Metsera Prepares for a Significant Presentation Metsera, Inc. (Nasdaq: MTSR) is poised to make a significant impact following the announcement that its Chief Executive Officer, Whit Bernard, will be presenting at the TD Cowen's 45th Annual Health Care Conference. Scheduled for a convenient time slot from 1:10 – 1:40 PM ET, this event will give Metsera an excellent...

Continue Reading
Tesla's Optimus Robot Stuns at Disney Event with Jared Leto

Updated Category News Views 400

Tesla's Groundbreaking Appearance at a Star-Studded Premiere Tesla Inc. (NASDAQ: TSLA) recently made waves at a high-profile event by showcasing its innovative Optimus humanoid robots. This event was none other than the premiere of The Walt Disney Company's latest film, which starred the well-known actor and musician Jared Leto. Illuminating Experiences with AI During the...

Continue Reading